New home shoppers can now use augmented reality to visualize what their potential new home may look like on their land before they break ground thanks to the release of an innovative new app. Clayton, a Berkshire Hathaway company and one of America’s largest homebuilders, announces the release of Home Previewer®, an iPhone® compatible app that allows shoppers to envision what a home may look like in 3D on their future home site. The free app is available for download from the App Store®.
“We’re pleased to be one of the first builders to introduce augmented reality to the digital home buying journey,” said Kevin Clayton, CEO of Clayton Homes. “Our homes now offer custom designs, innovative features and energy efficient upgrades. We are committed to being a leader in innovation for the home building community and will continue to develop the kind of technology that will support our customers throughout the experience.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8011651-clayton-launches-home-previewer-mobile-app/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
The fashion industry is changing. A trend transformation has already taken place this year with London Plus Size Fashion Weekend (LPSFW), the first of its kind which was held during this year’s spring / summer London Fashion Week.
Stylish plus size retailer Curvissa are continuing to celebrate this penchant for size, something which is expressed in their latest TV ad campaign.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60667-curvissa-summer-shoot-behind-the-scenes
